DEVELOPMENTAL FUNDS ? ABSTRACT Developmental Funds at KCI provide an important and essential source of funds in support of the Cancer Center?s investment in strategic initiatives. These initiatives are formalized through extensive planning and evaluation processes. During the past funding period, CCSG Developmental Funds were used in two key areas; 1) the recruitment of a key investigator in a Program leadership role, and 2) support of strategic pilot projects. CCSG funds were significantly augmented by institutional support to further recruitment efforts and provide funds for pilot projects aligned with KCI?s strategic priorities. Specifically, during the current grant cycle (12/1/2015 to 11/30/2019), $214,813 of CCSG Developmental Funds was augmented by an additional $14.8 million of institutional support to provide valuable support for 51 pilot projects consistent with the strategic vision of KCI and the recruitment of 36 new faculty, including 11 early stage investigators. The completed pilot projects have resulted in a five-fold return on investment measured by success in obtaining peer reviewed extramural funding. Additionally, new faculty level scientists have published 226 peer reviewed articles, secured 59 grant awards, and activated 129 clinical trials since their arrival. CCSG Developmental Funds in the amount of $55,550 are requested to fund pilot projects in the five areas of the Cancer Center?s focused future development. CCSG Developmental Funds, invested in pilot projects and augmented with institutional funding, have successfully driven innovative research and have led to extramurally funded projects over the course of the current grant cycle. This trend is expected to continue into the years to come, as KCI pursues the goals established in the strategic plan and engages with community partners to develop innovative projects that address the specific needs of the catchment area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088981
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Hastert, T A; de Oliveira Otto, M C; LĂȘ-Scherban, F et al. (2018) Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) 42:433-440
Bock, Cathryn H; Jay, Allison M; Dyson, Gregory et al. (2018) The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Res Treat 167:741-749
Mittal, Sandeep; Klinger, Neil V; Michelhaugh, Sharon K et al. (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414-421
Park, Hyo K; Schildkraut, Joellen M; Alberg, Anthony J et al. (2018) Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control 29:1081-1091
Heyza, Joshua; Lei, Wen; Watza, Donovan et al. (2018) Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res :
Bonomi, Robin; Popov, Vadim; Laws, Maxwell T et al. (2018) Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide. J Med Chem 61:7116-7130
Paximadis, Peter; Beebe-Dimmer, Jennifer L; George, Julie et al. (2018) Comparing Treatment Strategies for Stage I Small-cell lung Cancer. Clin Lung Cancer 19:e559-e565
Su, Yongwei; Li, Xinyu; Ma, Jun et al. (2018) Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem Pharmacol 148:13-26
Patki, Mugdha; McFall, Thomas; Rosati, Rayna et al. (2018) Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Sci Rep 8:16006
Teslow, Emily A; Bao, Bin; Dyson, Greg et al. (2018) Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells. Mol Oncol 12:1138-1152

Showing the most recent 10 out of 826 publications